Cefuroxime (2nd Gen) Injectable (IV, IM) bulk supplier for pharma manufacturers

Cefuroxime (2nd Gen) Injectable (IV, IM) 750 mg, 1.5 g, 3 g Suppliers & Bulk Manufacturers

Available Forms: Injectable (IV, IM)

Available Strengths: 750 mg, 1.5 g, 3 g

Reference Brands: Zinacef(US & EU)

Cefuroxime injectable binds to bacterial penicillin-binding proteins, inhibiting cell wall synthesis and causing bacterial lysis. It is effective against severe respiratory, urinary, and skin infections. Benefits include rapid, reliable bacterial eradication, broad-spectrum activity, good tissue penetration, and suitability for inpatient use, providing effective treatment for serious bacterial infections.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Cefuroxime (2nd Gen) Injectable (IV, IM)? List it or send an offer →

Product Description: Cefuroxime injectable, a 2nd generation cephalosporin, is approved in the EU and US for severe bacterial infections. In the EU, brands like Zinacef are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval relies on extensive clinical data, with generic options available. Both regions require detailed dossiers, including clinical trial results, manufacturing standards, and pharmacovigilance plans for approval and continuous safety monitoring. Due to its critical use, strict regulations on storage, labeling, and administration are enforced. We facilitate seamless market access for cefuroxime injections adhering to European and US standards.

Cefuroxime (2nd Gen) Injectable (IV, IM) — third party manufacturing & bulk supply

Cefuroxime (2nd Gen) Injectable (IV, IM) 750 mg, 1.5 g, 3 g is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Cefuroxime (2nd Gen) Injectable (IV, IM) is supplied as Injectable (IV, IM) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Cefuroxime (2nd Gen) Injectable (IV, IM) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Cefuroxime (2nd Gen) Injectable (IV, IM) →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Cefuroxime (2nd Gen) Injectable (IV, IM) is listed as Injectable (IV, IM) in 750 mg, 1.5 g, 3 g. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Cefuroxime (2nd Gen) Injectable (IV, IM) is referenced against Zinacef(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.